Data Foundry

Drug recalls 2026

Estradiol Gel — Class II drug recall D-0543-2026

Ongoing recall by ANI Pharmaceuticals, Inc., reported 2026-05-27, distributed nationwide. Defective Container; packets were found to be either empty or partially full.

Recall numberD-0543-2026
Product typeDrug
ClassificationClass II
StatusOngoing
Voluntary or mandatedVoluntary
Recalling firmANI Pharmaceuticals, Inc., Baudette, MN, United States
Recall initiated2026-05-12
Classified2026-05-20
Reported by FDA2026-05-27
DistributedNationwide (US)
Quantity3,964 cartons
Reason classespackaging
NDC70954-0530, 70954-0530-10, 70954-0530-20, 70954-0531, 70954-0531-10, 70954-0531-20, 70954-0532, 70954-0532-10, 70954-0532-20, 70954-0533, 70954-0533-10, 70954-0533-20, 70954-0534, 70954-0534-10, 70954-0534-20
Lot numbersM251109
Expiration dates2027-11-20

Product

Estradiol Gel, 0.1%, 0.25 mg, 0.25 g per packet, 30 packets per carton, Rx only, Distributed by: ANI Pharmaceuticals, Inc., Baudette, MN 56623. NDC 70954-531-20

Reason for recall

Defective Container; packets were found to be either empty or partially full.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0543-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.